| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | OMER | United States | $9.41 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#2 | PTEN | United States | $8.58 | $4,826,624,000.00 | Buy | 10 | 1995 |
#3 | ARRY | United States | $7.17 | $1,284,141,000.00 | Buy | 19 | 2020 |
#4 | INUV | United States | $1.14 | $86,209,305.00 | Strong Buy | 4 | 1996 |
#5 | RLMD | United States | $6.39 | $13,070.00 | Strong Buy | 5 | 2012 |
#6 | ADCT | Switzerland | $1.14 | $81,357,000.00 | Strong Buy | 4 | 2019 |
#7 | CABA | United States | $2.99 | $0.00 | Strong Buy | 6 | 2019 |
#8 | RWT | United States | $4.66 | $0.00 | Buy | 7 | N/A |
#9 | SOC | United States | $4.41 | $0.00 | Buy | 4 | N/A |
#10 | AQN | Canada | $5.46 | $0.00 | Buy | 8 | N/A |
#11 | TALK | United States | $5.20 | $0.00 | Buy | 6 | N/A |
#12 | DC | United States | $4.27 | $0.00 | Strong Buy | 4 | N/A |
#13 | TMC | Canada | $4.35 | $0.00 | Strong Buy | 5 | N/A |
#14 | METCB | United States | $7.91 | $0.00 | Strong Buy | 8 | N/A |
#15 | CRGY | United States | $9.47 | $3,579,782,000.00 | Buy | 12 | 2022 |
#16 | STLA | Netherlands | $5.82 | $0.00 | Buy | 5 | 2014 |
#17 | SRTA | United States | $5.28 | $0.00 | Strong Buy | 4 | N/A |
#18 | ONDS | United States | $7.93 | $50,731,000.00 | Strong Buy | 6 | 2015 |
#19 | URG | United States | $1.35 | $27,207,000.00 | Strong Buy | 5 | 2006 |
#20 | ARDX | United States | $5.16 | $2,607,000.00 | Strong Buy | 7 | 2014 |
#21 | LRMR | United States | $3.21 | $0.00 | Strong Buy | 6 | 2014 |
#22 | NG | Canada | $6.08 | $0.00 | Strong Buy | 6 | 2002 |
#23 | TLRY | Canada | $4.44 | $0.00 | Strong Buy | 4 | 2018 |
#24 | SENS | United States | $5.36 | $16,389,000.00 | Strong Buy | 4 | 2014 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $10 to Buy (July 2, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.